Introduction {#Sec1}
============

In Africa, infectious diseases are still a common and an important public health challenge; however, these disease patterns are changing, with a significant increase in the incidence rates of chronic diseases such as diabetes, hypertension, and cancer. Increased life expectancies and changing lifestyles, in addition to the high prevalence of specific infections are important contributing factors to the increased cancer burden \[[@CR1]\].

Cancer registries are an important public health surveillance tool by providing a census of cancer cases and are a major source of critical information for the planning of cancer control measures such as prevention, early detection, treatment and care \[[@CR2]\]. A February 2016 workshop held in Brazzaville, Republic of the Congo was co-organized by the International Atomic Energy Agency (IAEA), the World Health Organization's Regional Office for Africa (WHO-AFRO), the International Agency for Research on Cancer (IARC), the African Cancer Registry Network (AFCRN) and experts of Republic of the Congo-Brazzaville and concluded that "collecting patients' data in a comprehensive national registry is key to improve and effect cancer care in Africa" \[[@CR3]\]. Unfortunately, most African countries, including Angola, do not have a population-based cancer registry \[[@CR4]\], which limits the planning of tailored national and/or regional anti-cancer policies and calculation of cancer incidence and mortality rates and other important measures. In fact, for Angola cancer incidence and mortality rates were estimated by GLOBOCAN based on data from neighbouring countries \[[@CR5]\] and not from Angola itself. In June 2012, an integrated mission of IAEA's Programme of Action for Cancer Therapy (imPACT) to the Republic of Angola recommended to the Ministry of Health of Angola (MOH) that cancer registration in the country be improved, which included training staff in cancer registration methods.

The Instituto Angolano de Controlo do Cancer (IACC) in Luanda (formerly the National Oncology Centre), is the oldest public centre for the treatment of cancer patients in Angola and hosts a hospital-based cancer registry. In 2015, Armando A et al. published the most common cancers in the IACC registry from 2007 to 2011, namely cervix cancer, breast and prostate cancer \[[@CR6]\]. As the majority of cancer cases in Angola are treated in this facility, the IACC's registry holds the potential to provide an estimate of the epidemiological profile of cancer in the Angolan population. Acknowledging this potential, in 2014 AFCRN experts recommended consolidating the existing IACC cancer registry and transforming it into a population-based cancer registry for the region of Luanda. Luanda is the largest city in Angola with 5,531,546 inhabitants in 2015 \[[@CR7]\]. (Fig. [1](#Fig1){ref-type="fig"}). Fig. 1Luanda city population pyramid estimated for 2015. NIS -- National Institute of Statistics

The present study aims to describe the structure of the IACC's hospital-based cancer registry (HBCR) including its challenges with data collection, reporting, and analysis in addition to providing an overview of the most frequent tumours, by age and gender in the registry. The potential for the registry to be used for estimating population-level cancer incidence rates for Angola and to propose priorities for activities to transform the IACC hospital-based cancer registry into a population-based cancer registry for Luanda are also discussed.

Methods {#Sec2}
=======

*Data sources* for the *registry* {#Sec3}
---------------------------------

The IACC hospital-based cancer registry provides the majority of the specialized cancer management services in Angola. The HBCR/IACC record for each cancer patient the following data: first name and surname, date of birth or approximate age, identification number, gender, marital status, ethnic origin, current residential address, place of birth, date of cancer diagnosis, histology/cytology number, tumour site and histology type, clinical stage of disease, basis of diagnosis, treatment given, vital status, and date and cause of death.

The registry employs passive methods of case finding and receives information from two semi-private institutions in Luanda, *Clínica Sagrada Esperança* and *Clínica Girassol,* which are involved in the management of cancer patients \[[@CR6]\]. The HBCR/IACC also receives notifications from the *Américo Boavida Hospital*, *Josina Machel Hospital*, *Lucrécia Paim Maternity Hospital*, *and David Bernardino Pediatric Hospital* on a voluntary basis, as well as, information about cancer patients referred by the Health Minister for treatment abroad.

The primary data sources are the inpatient wards and oncology outpatient clinics of IACC. Additionally, records of specific cancer research studies are included. Information from the other public hospitals in Luanda, (*Prenda* Hospital, Central Military Hospital, *Augusto Ngangula* Maternity) is only included in the registry when the patient is transferred to the IACC for eventual treatment or multidisciplinary team discussion. Currently, there is no active case finding and minimal follow-up of cases performed by HBCR/IACC.

Quality of the data {#Sec4}
-------------------

In Angola, the diagnosis of primary tumours is mainly obtained with the support of histology and cytology data, but clinical diagnoses reported by hospitals are also included. Death certificates are used less frequently as they are considered to be of poor quality.

Data collection and storage {#Sec5}
---------------------------

Each case report form is coded and entered into a Microsoft Excel spreadsheet created for the HBCR/IACC. Since 2014, the HBCR began using IARC's CanReg5 to store, check, and validate the records. Each case receives a unique cancer registry identification number and the tumour site and morphology are coded according to the third edition of the International Classification of Diseases for Oncology \[[@CR8], [@CR9]\].

Data analysis {#Sec6}
-------------

We performed a descriptive analysis of the IACC HBCR data for the time period 2012--2016. Cases with missing or incomplete data were excluded from the analysis. In addition, this analysis included an evaluation of data consistency according to AFCRN recommendationsand results are provided in numbers and proportions \[[@CR8]\].

Age-standardized (ASR) incidence rates for the Luanda region expressed per 100,000 person-years, considering only the cases diagnosed in Luanda, were computed by the direct method using the World Health Organization's standard population as the reference \[[@CR10]\]. All hypothesis tests were two-sided, and *P* values \< 0.05 were considered statistically significant. Statistical analyses were performed using SPSS version 21 (New York, NY).

Results {#Sec7}
=======

Analysis of new reported cancer cases and method of diagnosis {#Sec8}
-------------------------------------------------------------

From 2012 to 2016, 6638 new cancer cases were registered in the HBCR at IACC. Of these, 644 cases (10%) were considered duplicates and 200 cases (3%) were not assigned a diagnosis and excluded from the analyses. From 5794 cases, the proportion of cases which had a microscopically verification (histology or cytology) was 92.3, 6.7% had clinical diagnosis only, and 1.0% were registered through death certificates only. Non-melanoma skin cancers were diagnosed in 185 patients, and excluded from further analysis, which is the standard practice in cancer registry reports and allows for international comparisons. The final analyses were conducted on 5609 new cancer cases.

Analysis of the distribution of reported cancers by age, site and gender {#Sec9}
------------------------------------------------------------------------

Of the 5609 cancer cases, the mean age at diagnosis was 45.4 years with a standard deviation (SD) of 19.5 years. Females accounted for 63.3% of the cancer cases in the HBCR. Age at diagnosis was not statistically significant between males and females (45.2 and 45.5, respectively, *p* = 0.65). The male/female ratio was 0.58.

For the time period studied, the five most common cancers were: breast (21.4%), cervix (16.8%), prostate (7.1%), non-Hodgkin lymphoma (4.5%) and Kaposi sarcoma (4.3%). For males, 19.3% of the cancers were prostate, 7.5% Kaposi sarcoma, and 7.5% non-Hodgkin lymphoma. Cancers of the breast and cervix together accounted for almost 60% of all cancers in females (Table [1](#Tab1){ref-type="table"}). Table 1Distribution of the number of cancers by site and gender from the IACC hospital-based cancer registry, 2012--2016TotalMaleFemaleCancer SiteNo.%No.%No.%Lip and Oral Cavity1753.11035.0722.0Nasopharynx240.4180.960.2Oesophagus1322.4954.6371.0Stomach1753.1904.4852.4Colon and Rectum1552.8944.6611.7Liver1412.5854.1561.6Gallbladder160.360.3100.3Pancreas340.6190.9150.4Nasal Cavity and Middle Ear300.5160.8140.4Larynx761.4653.2110.3Lung991.8693.4300.8Melanoma of Skin561.0211.0351.0Bone681.2361.7320.9Kaposi Sarcoma2414.31547.5872.5Connective and Soft Tissue1823.2964.7862.4Breast120021.4341.7116632.8Cervix Uteri94416.8----94426.6Corpus Uteri741.3----742.1Ovary761.4----762.1Prostate3977.139719.3----Kidney1903.4994.8912.6Bladder761.4331.6431.2Eye1813.2834.0982.8Brain and CNS410.7150.7260.7Thyroid370.7130.6240.7Hodgkin Lymphoma400.7211.0190.5Non-Hodgkin Lymphoma2534.51547.5992.8Multiple Myeloma430.8160.8270.8Leukaemia1352.4763.7591.7Other and Unspecified Cancers3185.71517.31674.7All cancers, excluding non-melanoma skin cancer560910020591003550100Legend: *CNS* Central Nervous System

Analysis of the distribution pattern of reported cancers by site and year of diagnosis {#Sec10}
--------------------------------------------------------------------------------------

Between 2012 and 2016, the highest number of registered cases was 1232 new cases in 2013 (22% of all periods) and the lowest was in 2012 with 974 (17%) new cases in this quinquennium (Table [2](#Tab2){ref-type="table"}, Additional file [1](#MOESM1){ref-type="media"}). Of the ten most common types of cancer, prostate and non-Hodgkin lymphoma, displayed a very different distribution pattern of the other common cancer types over the specified time period. The gender distribution was similar from 2012 to 2016. Table 2Distribution of the number of cancers by site and year of diagnosis from the IACC hospital-based cancer registry, 2012--2016. Distribution of all reported cases from 2012 to 2016 by gender is available in supplementary data (Additional file [1](#MOESM1){ref-type="media"})Cancer Site20122013201420152016TotalLip and Oral Cavity1735394341175Stomach3338383135175Kaposi Sarcoma4957494442241Connective and Soft Tissue3340343837182Breast2183081942442361200Cervix Uteri171175203195200944Prostate10988419267397Kidney4033513729190Eye3028454731181Non-Hodgkin Lymphoma5273445628253Other and Unspecified Cancers2223573863593471671Total97412321124118610935609

The mean age at diagnosis was 45.4 years old, SD ± 19.5 (45.2 for males and 45.5 for females). Breast and cervical cancers were the two most frequent cancer types each year. Other than breast and cervical cancers, there were variations in the relative frequency of the other cancer types, such as prostate cancer, non-Hodgkin lymphoma, Kaposi sarcoma, and cancers of the oral cavity, which were amongst the most commonly diagnosed.

Analysis of the distribution pattern of reported cancers by place of residence {#Sec11}
------------------------------------------------------------------------------

From all cancer cases, over 80 % (4607 cases) in the HBCR were residents from the Luanda district. There were no differences in the proportions of breast (Luanda residents - 33% vs people living in other areas of Angola- 32%) and cervix uteri (Luanda - 27% vs people living in other areas of Angola - 26%) cancers. However, there were a higher proportion of prostate cancer cases among patients living in urban Luanda (Luanda residents - 20% vs people living in other areas of Angola - 5%). On the contrary we found higher proportion of retinoblastoma (Luanda - 3% vs people living in other areas of Angola - 5%), kidney cancer (Luanda - 3% vs people living in other areas of Angola - 5%), and non-Hodgkin lymphoma (Luanda - 4% vs people living in other areas of Angola - 6%) diagnosed in residents living outside Luanda.

Analysis of the distribution pattern of reported cancers in children (\< 15 years old) {#Sec12}
--------------------------------------------------------------------------------------

There were 543 new cancer cases (9.7%) reported over 2012--2016 among paediatric patients in the IACC HBCR aged less than 15 years. Of these 543, slightly more than half (55.6%) were male. Amongst this patient population, the most common cancer types were Wilms' tumour, retinoblastoma, and non-Hodgkin lymphoma, corresponding to 64.4% of the total of cancers reported for this age group (Table [3](#Tab3){ref-type="table"}). Table 3Distribution of the number and percentage of childhood cancers by site and gender from the IACC hospital-based cancer registry, 2012--2016TotalMaleFemaleCancer SiteNo%No%No%Connective and Soft Tissue417.6258.3166.6Wilms' Tumour14126.07123.57029.0Retinoblastoma12122.36120.26024.9Non-Hodgkin Lymphoma8816.26220.52610.8Leukaemia478.7278.9208.3Other and Unspecified Cancers10519.35618.54920.3All cancers, excluding non-melanoma skin cancer543100.0302100.0241100.0

Calculation of age-standardized incidence rates for the Luanda region {#Sec13}
---------------------------------------------------------------------

The age-standardized incidence rates of the five most common cancer types for the Luanda region were calculated (Table [4](#Tab4){ref-type="table"}). In males, the highest age-standardized incidence rate was prostate (7.9) followed by Kaposi sarcoma (1.8), lip and oral cavity (1.4), stomach (1.4) and non-Hodgkin lymphoma (1.22) at the lowest. In females, the highest age-standardized incidence rate was for breast (13.7) followed by cervix uteri (11.7), stomach (1.3), non-Hodgkin lymphoma (0.8) and Kaposi sarcoma (0.8) with the lowest rate. Figures [2](#Fig2){ref-type="fig"}, [3](#Fig3){ref-type="fig"}, and [4](#Fig4){ref-type="fig"} show the age-specific rates for prostate, breast, and cervix uteri cancers, respectively. Table 4Top-five age-standardized incidence cancer rates per 100,000 person-years in the Luanda region, by gender from the IACC hospital-based cancer registry, 2012--2016Age-Standardized Rates per 100,000RankMaleFemale1Prostate -- 7.9Breast -- 13.72Kaposi Sarcoma -- 1.8Cervix Uteri -- 11.73Lip and Oral Cavity -- 1.4Stomach -- 1.34Stomach -- 1.4Non-Hodgkin Lymphoma -- 0.85Non-Hodgkin Lymphoma -- 1.2Kaposi Sarcoma -- 0.8 Fig. 2Age-specific incidence rates per 100,000 for prostate cancer from the IACC hospital-based cancer registry, 2012--2016 Fig. 3Age-specific incidence rates per 100,000 for breast cancer from the IACC hospital-based cancer registry, 2012--2016 Fig. 4Age-specific incidence rates for cervix uteri cancer from the IACC hospital-based cancer registry, 2012--2016

We compared our HBCR data to the five most common tumours, by gender according to IACR's GLOBOCAN 2018 (Table [5](#Tab5){ref-type="table"}). Data from Namibia, the Republic of the Congo-Brazzaville, and Zambia (all bordering Angola), were used to calculate the GLOBOCAN 2018 estimates \[[@CR11]\]. There are differences between the most common tumours observed in the IACC HBCR and those published by GLOBOCAN. Table 5Estimated Top-five cancer types in 2018 (Angola, Congo, Zambia and Namibia) and Luanda Region (2012--2016)CountryLuanda Region\
(2012--2016)Angola^a^\
GLOBOCAN 2018R. Congo^b^\
GLOBOCAN 2018Zambia^c^\
GLOBOCAN 2018Namibia^d^\
GLOBOCAN 2018MenWomenMenWomenMenWomenMenWomenMenWomen**1stProstateBreastProstate**Cervix U.**ProstateBreastProstate**Cervix U.**ProstateBreast2ndKaposi S.Cervix U.**LiverBreastLiver**Cervix U.Kaposi S.**Breast**Kaposi S.Cervix U.3thLip, Oral CavityStomach**ColorectalColorectalColorectalColorectalNHLKaposi S.**Lip, Oral Cavity**Kaposi S.**4thStomachNHL**NHLEye**Stomach**OvaryOesophagus**NHL**ColorectalColorectal**5thNHLKaposi S.**LungOvaryLungLiverColorectalColorectalLungOvary*NHL* non-Hodgkin lymphoma; *Kaposi S*. Kaposi sarcoma; *Cervix U* Cervix uteri. ^a^Estimative according simple average of Congo, Zambia and Namibia rates. ^b^Rates from Brazzaville (2010--2014) applied to 2018 population; ^c^Rates from Lusaka (2011.-2015) applied to 2018 population; ^d^Rates from Namibia (2010--2014) 4 applied to 2018 population. Bold - cancer site equal across the different estimations and the Luanda region.

Discussion {#Sec14}
==========

The cancer registries in most Sub-Saharan Africa countries are constrained in the collection of all cancer cases whether throughout the entire country or in specific regions. Therefore, accurate incidence rates are almost impossible to calculate due to lack of resources and organization to collect the needed data \[[@CR12]\], which is the current situation in Angola. The best cancer registries occur in hospital units and where there is willingness to coordinate the collection and storage of these records centrally. However, creating cancer registries in hospitals, which was one of the recommendations of the AFCRN in 2014, has not been adequately implemented in Sub-Saharan Africa. This is a challenge in Angola due to several difficulties in expanding the current IACC hospital-based registry into a population-based registry.

Characterization of HBCR/IACC {#Sec15}
-----------------------------

Currently, the IACC is insufficiently staffed to conduct active data collection in other hospitals, pathology laboratories, and health care facilities in Luanda. Moreover, information from death certificates is not available from General Register Offices and the existing death certificate information that is available is considered by the professionals interviewed during the AFCRN site visit to be of too poor quality to be useful for inclusion in a cancer registry. In this study, we identified several issues related to the quality of the information available in the IACC HBCR, such as missing data, duplicate case records, and data inconsistencies \[[@CR13]\]. However, despite these limitations, the only data currently available in Angola is from the IACC hospital-based registry.

Valuable information and limitations identified {#Sec16}
-----------------------------------------------

Despite these data limitations available in the HBCR, our study is the largest, most complete, and the only study in which quality control of the data was conducted amongst cancer incidence studies conducted in Angola. In this study, missing and incomplete data were excluded from the analyses. In comparison to the data previously published by Armando and colleagues \[[@CR6]\]. Regarding IACC HBCR for the time period 2007 to 2011, we verified that the global number of malignant tumours diagnosed per year increased. Cervical, breast, and prostate cancers are in the top three cancers ranked by incidence and accounted for a significant portion of the overall cancer burden in Angola. Interestingly, the number of cases with Kaposi's sarcoma decreased slightly in comparison to the previous period of analysis \[[@CR6]\].

The lower number of cases in 2016, as compared to the previous years can be explained in part, by the delay in the notification of new cancer cases and inconsistent data received from these other institutions that submit data to the IACC HBCR. However, the opening of other cancer care facilities and institutions and traveling for cancer treatment in Namibia and South Africa may also have contributed to the lower number of cases reported in Angola for this year \[[@CR14]\].

The decreasing number of prostate cancer case records is likely due to underreporting. A private clinical unit dedicated to the treatment of urological cancer was established in Luanda; however, these cancer cases are not yet reported to the IACC HBCR and there was no urology clinic or specialized service for prostate cancer in the IACC during the studied period.

Regarding paediatric patients, Wilms' Tumour, retinoblastoma and Non-Hodgkin's Lymphoma were the most frequent tumours diagnosed at the IACC. The observed profile of paediatric cancers was similar to the prevalent tumours described recently by Wy and colleagues and by Stefan and colleagues when they analysed African paediatric cancer registries \[[@CR15], [@CR16]\].

In addition, we compared our data to the five most frequent tumours, by sex, according to GLOBOCAN 2018 for Angola. This comparison highlighted the potential deviation from the reality in many countries that estimates may have. A reliable study of cancer incidence rates, or time trends, integrating the limited existing data into mathematical models of incidence estimates may result in a closer and more realistic picture of cancer burden in Angola than the current models that only take into account estimates from neighbouring countries.

However, our results should not be considered in the GLOBOCAN estimates given that we observed too many fluctuations in numbers being diagnosed each year and other data limitations thereby suggesting a very large misclassification of some cancer cases at the IACC and other participating institutions.

Proposal to optimize the IACC's HBCR {#Sec17}
------------------------------------

Although the gold standard for cancer registration is population-based cancer registries, these are not always available in many countries \[[@CR17], [@CR18]\]. In these circumstances, HBCR may provide a starting point for determining cancer occurrence in a region or country. For example, Jedy-Agba and colleagues \[[@CR19]\]. analyzed the role of hospital-based cancer registries in Nigeria and concluded that information provided by these registries is beneficial and could be used for the improvement of cancer care delivery systems in low and middle-income countries in the absence of population-based cancer registries. Thus, upgrading hospital-based cancer registries to population-based cancer registries in these regions is of paramount importance and should be a priority of a government \[[@CR19]\].

As a result, dedicated oncology clinical units are under development in the most important general hospitals in Luanda and these units are comprised of a medical oncologist and a dedicated nurse. Tumour registrars, who will be part of the hospital registry service, are also included. Thus, a registry office for cancer cases in the main hospitals in Luanda was established and will serve as the primary source of information for the future population-based Luanda Cancer Registry. In Angola, despite our efforts in creating and maintaining the hospital-based cancer registry at the IACC, the true total burden of cancer, as well as, the details of cancer types, remains largely unknown.

It is strategic that cancer became a notifiable disease under Angolan law for both the public and private sectors. All cases of cancer diagnosed in Luanda hospitals, even without microscopic confirmation, are to be reported to population-based cancer registry, as proposed by the AFCRN \[[@CR8], [@CR20], [@CR21]\]. The location of this cancer registry is (or should be), according to the Angolan law, the IACC \[[@CR6]\]. All death certificates that mention cancer under the local health authority's control must notify to the cancer registry. The newly-diagnosed cancer cases in the capital city should be actively collected from all hospitals, clinics, and diagnostic facilities. Additionally, the IACC hospital-based cancer registry quality control program should be instituted and followed by all hospitals where cancers are diagnosed and treated in Luanda (Table [6](#Tab6){ref-type="table"}). Table 6IACC hospital-based cancer registry quality control programStandardsQuality control activitiesPlace/supportCapacity buildingAppropriate training of tumor registrars and research assistantsPortuguese Institute of Cancer, Porto, Portugal and Beira Cancer registry, MozambiqueCapacity buildingAdditional support provided by the Portuguese Institute of Cancer, Porto, Portugal cancer registry staff.Portuguese Institute of Cancer, Porto, Portugal by teleconferenceInternal organizationUsing the Standard Procedure Manual for Population-Based Cancer Registry in sub Saharan Africa.<https://afcrn.org/index.php/resources2/53-standard-procedure-manual> (20)Internal organizationUsing the AFCRN Data Collection FormPortuguese translation of AFCRN Data Collection Form<https://afcrn.org/index.php/resources2/56-data-collection-form> (8)Improving the quality of cancer registryComparing hospital medical record and tumor registry dataIACCImproving the quality of cancer registryReviewing by research assistant to check accuracy of gender, age, histologic and morphologic diagnosis of the patients according to ICD-O 3,IACCImproving the quality of cancer registryCrosschecks by research assistant to increase the consistency of the databaseIACCImproving the quality of cancer registryRevise and record of inaccurate dataIACCImproving the quality of cancer registryValidation of data by using quality control programs/tools of International Agency for Research on Cancer (IARC) for avoiding duplication and any unlikely combination of age, sex, site and morphology and other factors in the database (CanReg 5).IACCImprove the cancer registry network in order to start an Population-based cancer registry of LuandaAppropriate training of tumor registrars of other hospitals, in particular: Américo Boavida Hospital, Josina Machel Hospital, Lucrécia Paim Maternity Hospital, David Bernardino Pediatric Hospital, Prenda Hospital, Central Military Hospital and Augusto Ngangula MaternityIACC and Portuguese Institute of Cancer, Porto, Portugalworkshop on the population-based cancer registry of LuandaAll hospitals in LuandaIACC and Ministry of Health

Conclusions {#Sec18}
===========

The IACC hospital-based cancer registry provides data on cancer cases treated in several hospital facilities in Luanda. However, this data cannot be considered a reflection of the situation in Luanda (nor Angola) as a whole, as data are not truly a population-based registry. Therefore, in order to overcome the IACC cancer registry limitations identified and to build a population-based cancer registry in Luanda, it is mandatory to implement a rigorous quality control program and to optimize the network of health institutions that actively working on and contributing to the cancer registry, in Luanda.
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**Additional file 1.** Distribution of all reported cases from 2012 to 2016 by gender (supplementary data)
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